Last reviewed · How we verify
The Effects of the Combination of Welchol and Tricor Compared to TriCor Alone in Patients With Mixed Hyperlipidemia
The primary objective of this study is to compare the effect of Welchol in combination with TriCor compared to TriCor alone on low-density lipoprotein cholesterol (LDL-C) in patients with high cholesterol.
Details
| Lead sponsor | Daiichi Sankyo |
|---|---|
| Phase | Phase 4 |
| Status | COMPLETED |
| Enrolment | 129 |
| Start date | 2003-02 |
| Completion | 2004-03 |
Conditions
- Hypercholesterolemia
- Hyperlipidemia, Familial Combined
Interventions
- colesevelam HCl tablets and fenofibrate tablets
- fenofibrate tablets and Welchol placebo tablets
- fenofibrate tablets and Welchol placebo tablets
Primary outcomes
- % change in LDL-C from baseline — 6 weeks
Countries
United States